NIAAA has issued a Notice of Special Interest (NOSI) for administrative supplements and competitive revisions focused on urgent research questions of significance to alcohol and the COVID-19 pandemic (NOT-AA-20-11). NIAAA is also participating in other NIH NOSIs and funding opportunities focused on COVID-19 research questions. These NOSIs are linked to PA-18-591 (administrative supplement) and PA-18-935 (urgent competitive revision).

Administrative supplement requests related to hardships caused by the COVID-19 pandemic should also refer to the NIAAA-specific requirements at https://www.niaaa.nih.gov/grant-funding/application-process/administrative-supplements. 

If you have questions, please contact either the NIAAA point-of-contact listed below, NIAAA program staff (https://www.niaaa.nih.gov/extramural-research), or Dr. Philippe R Marmillot (marmillotp@nih.gov) 

NIAAA Issued COVID NOSI:

• NOT-AA-20-011: Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA; NIAAA Contact: Dr. Kathy Jung (jungma@mail.nih.gov or 301-443-8744)

NIAAA Issued COVID RFAs:

• RFA-AA-21-003: SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)

• RFA-AA-21-002: SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)

• RFA-AA-21-004: SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)

NIH-wide COVID NOSIs and RFAs with NIAAA’s participation:

• NOT-NS-20-051: Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System; NIAAA Contact: Dr. Changhai Cui (changhai.cui@nih.gov or 301-443-1678)

• NOT-OD-20-103: Notice of Additional Due Date and Additional Areas of Focus Especially of Interest of PAR-19-373 and PAR-19-384, "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)"; NIAAA Contact: Dr. Changhai Cui (changhai.cui@nih.gov or 301-443-1678)

• NOT-MH-20-047, Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus; NIAAA Contact: Dr. Laura Kwako (laura.kwako@nih.gov or 301-451-8507)

• NOT-OD-20-097, Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences; NIAAA Contact: Dr. Mike Hilton (mhilton@willco.niaaa.nih.gov or 301-402-9402)

• NOT-RM-20-015, Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

• NOT-AT-20-011, Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19); NIAAA Contact: Dr. Laura Kwako (laura.kwako@nih.gov or 301-451-8507)

• NOT-MD-20-019: Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities; NIAAA Contacts: Dr. Laura Kwako (laura.kwako@nih.gov or 301-451-8507) and Dr. Judith Arroyo (jarroyo@mail.nih.gov or 301-402-0717)

• NOT-AG-20-022: Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19); NIAAA Contact: Dr. Changhai Cui (changhai.cui@nih.gov or 301-443-1678)

• NOT-MD-20-022: Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations; NIAAA Contact: Dr. Kathy Jung (jungma@mail.nih.gov or 301-443-8744)

• NOT-MH-20-058: Notice of Intent to Publish a Notice of Funding Opportunity for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional)

• NOT-MH-20-053: Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19

• RFA-OD-20-013:Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)

• NOT-OD-20-119: Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations; NIAAA Contact: Dr. Judith Arroyo (jarroyo@mail.nih.gov or 301-402-0717)

• NOT-OD-20-120: Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations; NIAAA Contact: Dr. Judith Arroyo (jarroyo@mail.nih.gov or 301-402-0717)

• NOT-OD-20-121: Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations; NIAAA Contact: Dr. Judith Arroyo (jarroyo@mail.nih.gov or 301-402-0717)

• PAR-20-237: Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional); NIAAA Contact: Dr. Laura Kwako (laura.kwako@nih.gov or 301-451-8507)

Additional COVID-19-related information for applicants and recipients of NIH funding is available on the NIH Office of Extramural Research’s website Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding or https://grants.nih.gov/policy/natural-disasters/corona-virus.htm.